Arterra Bioscience S.p.A.

€3.02As of Sun 8 Nov 2026, 12:00 UTC
BIT:ARBSHealthcare
Country Italy
PE (Fwd) •••
TSR 7Y CAGR 1.77%
Div yield 4.30%
ROE 13.86%
Biotechnology
Beta (5Y) 0.57
PE TTM 12.09
TSR TTM 3.75%
Mkt cap €20.11M
ROIC 14.26%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€3.47
15.04%
(66.47%)
Buy 11|10|1|6|0
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.03
0.03
0.03
0.03
21.65%
19.75%
3.50%
8.73%
Revenue€M
2.798
2.809
2.890
2.946
14.47%
11.90%
9.74%
10.99%
Peers (US$22.58M)
Cap (US$)
PE
17.74M
—
22.58M
—
Capital
TTM
5Y
10Y
Leveragex
0.153
(0.101)
(0.086)
EBIT/Intx
0.768
0.448
0.342
Own earn%
(32.10)
(89.17)
(49.25)
Sh yield%
24.79
24.75
24.01
Owners
Insiders/Inst%
9.25
74.04
Short interest%
2.90
SBC / revenue%
1.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
3–6
$1 testx
4.5
Incr. ROIC%
6